Hongxin Huang

9PUBLICATIONS
44CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Satisfiability and optimisationPredictive and prognostic markersDigital writing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 22, 2026
Targeting VEGF signaling and stromal remodeling enhances chemoimmunotherapy efficacy in esophageal cancer.

|Dec 12, 2025
In situ DC-primed vaccine combined with CD137 agonist elicits long-lasting antitumor immunity through cDC1-mediated tumor antigen-specific CD8<sup>+</sup> T cell responses.

Mengjiao Wang, Li Qiu, Cheng Tang

|Mar 28, 2025
Engineered circular guide RNAs enhance miniature CRISPR/Cas12f-based gene activation and adenine base editing.

Xin Zhang, Mengrao Li, Kechen Chen

|Oct 19, 2023
Correction: Profiling the impact of the promoters on CRISPR-Cas12a system in human cells.

Jinhe Li, Qingchun Liang, HuaPing Zhou

|Jun 23, 2023
Engineered circular guide RNAs boost CRISPR/Cas12a- and CRISPR/Cas13d-based DNA and RNA editing.

Xin Zhang, Xinlong Wang, Jie Lv

|May 17, 2023
Profiling the impact of the promoters on CRISPR-Cas12a system in human cells.

Jinhe Li, Qinchun Liang, HuaPing Zhou

Pageof 2

Frequent Collaborators

5 joint publications

Ying Lin

5 joint publications

Zhili Rong

4 joint publications

Tao Huang

3 joint publications

Xin Zhang